Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature achieves ‘The Sunday Times Heathrow SME Export Track 100’ for the 2nd year running

We are delighted to announce that Sygnature Discovery has been placed No 65 in The Sunday Times Heathrow SME Export Track 100 published in the Business section of The Sunday Times on 15th May 2016. The listing reflects Sygnature’s continued advances in supporting the  global pharmaceutical industry with early stage drug discovery expertise.

Latest News

View All

RenaSci’s Sharon Cheetham awarded BPS Fellowship

Sygnature Discovery invests in high-throughput screening capability

Sygnature Discovery moves US base to Kendall…

Sygnature Discovery raises over £2,776 for Cancer…

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.